Wednesday, February 10, 2010, 2:46PM AEST - The Australian Stockmarket closes in 1 hour and 19 minutes.
To create a watchlist or portfolio of shares, Register

Sanofi-Aventis (SNY)

8:02AM AEST: 36.29 USD  Up 0.38 (1.06%)  
 MORE ON SNY 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 SANOFI-AVENTIS SA (NYSE:SNY) Delayed quote dataEdit
Last Trade:36.29 USD
Trade Time: 8:02AM AEST
Change:Up 0.38 (1.06%)
Prev Close:35.91
Open:35.94
Bid:N/A
Ask:N/A
1y Target Est:42.50
Day's Range:35.88 - 36.68
52wk Range:24.59 - 41.59
Volume:1,187,058
Avg Vol (3m):1,409,300
Market Cap:94.76B
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:1.42 (3.95%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add SNY to Portfolio   Download Data

 HEADLINES 
Pfizer Off 2% As 2010 Targets Miss; Posts Revised 2012 Targets
at Barrons.com (Wed 12:20PM)
Bone Up On This Potential Blockbuster
at Motley Fool (Wed 3:58AM)
Europe Launches Probe into Pharma Deals
at BusinessWeek (Wed 2:52AM)
Germany Cancels Swine Flu Vaccines
at BusinessWeek (Wed 2:52AM)
Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.
PR Newswire (Tue 5:36PM)
Aker Solutions dented by contract woes
at FT.com (Tue 7:35AM)
Large Pharma and Small Biotech Deals Expected to Increase in 2010
at Seeking Alpha (Mon, Feb 8)
[$$] Sanofi to decide soon on reviving Merck venture
at The Wall Street Journal Online (Mon, Feb 8)
How Big Pharma Got in This Fix
at Seeking Alpha (Mon, Feb 8)
Week Ahead: Market Still Feels Sting of the Credit Crisis
at CNBC (Sat, Feb 6)
/R E P E A T -- Media Alert - Garry Galley winds up from the blue line to Take a Shot for Meningitis Awareness/
CNW Group (Fri, Feb 5)
Glaxo Brings Home the Bacon
at Motley Fool (Fri, Feb 5)
Surfing the Wave of the Future: Personalized Medicine
at Motley Fool (Fri, Feb 5)
More Headlines for SNY...

 ANALYST 
EPS Est (next year) (Dec-09) :7.76
EPS Est (in 2 years) (Dec-10) :7.72
Avg Rec (current)*:2.3
PEG Ratio:2.06
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Sanofi-Aventis, a pharmaceutical company, contributes to enhancing life by providing an offering of medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices